Research Article
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
Table 2
The symptoms and signs of 14 LEMS patients with lung cancer.
| Symptoms | No. of patients (%) |
| Onset | ā | Gradual | 11 (78.6%) | Acute | 3 (21.4%) | Respiratory symptoms and/or signs | 8 (57.1%) | Muscle weakness | 13 (92.9%) | Leg weakness | 13 (92.9%) | Proximal | 13 (92.9%) | Distal | 7 (50.0%) | Upper extremity weakness | 4 (28.6%) | Proximal | 4 (28.6%) | Distal | 2 (14.3%) | Respiratory muscle weakness | 3 (21.4%) | Cranial nerve weakness | 5 (35.7%) | Ocular muscle weakness | 3 (21.4%) | Oropharyngeal symptoms | 4 (28.6%) | Autonomic dysfunction | 10 (71.4%) | Dry mouth | 8 (57.1%) | Dry eyes | 3 (21.4%) | Constipation | 6 (42.9%) | Male impotence | 2 (14.3%) | Orthostatic hypotension | 2 (14.3%) | Decreased or absent tendon reflexes | 7 (50.0%) | Restrictive ventilatory dysfunction | 3 (21.4%) |
|
|